ScholarIQanswers from OpenAlex

Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012

PaperCitations, authors & open-access status

Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 have?

ScholarIQcitation count

Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 has 92 citations in the OpenAlex counts ScholarIQ stores.

When was Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 published?

ScholarIQyear

Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 has 2017 year in the ScholarIQ index.

What is the open-access status of Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012?

ScholarIQoa status

Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 has closed oa status in the ScholarIQ index.

What is the DOI of Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012?

ScholarIQdoi

The DOI for Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 is on the source record.

What is the PMID of Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012?

ScholarIQpmid

The PMID for Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 is on the source record.

What is the OpenAlex record for Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012?

ScholarIQopenalex

The OpenAlex for Trends in Treatment and Mortality for Mesenteric Ischemia in the United States from 2000 to 2012 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial